Carrie Gavit

Verdict on Oklahoma J&J trial set for Monday; Pfizer invests $500 million in North Carolina facility; Designer drugs drive overdose increase on West Coast.

Novartis ousts scientists involved in data manipulation; Lawmakers accuse drugmakers of stonewalling price investigation; Tilray reports wider-than-expected loss.

FDA investigates post-vaping seizures; Narasimhan defends Novartis; Kellyanne Conway confirms September rollout of Trump healthcare plan.

HHS, FDA detail drug-importation plan; PhRMA, BIO oppose proposal; Big tech comes together to help patients access medical info.

House Oversight Committee calls out Juul; Wearables have trouble tracking heartbeats of people of color; FDA asks Allergan to recall breast implants.

Federal Reserve chair says opioid crisis has had ‘quite substantial’ economic impact; GSK hires Genentech veteran to oversee AI; Amazon partners with Britain’s NHS.